Cargando…

Observation of dose dependent intravaginal Prostaglandin E2 application in free farrowing sows during parturition – a pilot study

The duration of birth is an important factor influencing the survival of piglets and the health of sows. A prolonged parturition is usually treated with oxytocin, even though several undesirable side effects are described. Therefore, the aim of this study was to evaluate the safety and efficacy of P...

Descripción completa

Detalles Bibliográficos
Autores principales: Grahofer, Alexander, Bill, Ramona, Nathues, Heiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017699/
https://www.ncbi.nlm.nih.gov/pubmed/33810812
http://dx.doi.org/10.1186/s40813-021-00208-z
_version_ 1783674099889864704
author Grahofer, Alexander
Bill, Ramona
Nathues, Heiko
author_facet Grahofer, Alexander
Bill, Ramona
Nathues, Heiko
author_sort Grahofer, Alexander
collection PubMed
description The duration of birth is an important factor influencing the survival of piglets and the health of sows. A prolonged parturition is usually treated with oxytocin, even though several undesirable side effects are described. Therefore, the aim of this study was to evaluate the safety and efficacy of Prostaglandin E2 (PGE2) of different concentrations as an intravaginal applied gel after the birth of the fourth piglet in sows. Twelve sows were randomly allocated to one of four treatment groups: Group I (control group) application of placebo gel; Group II application of 0.5 mg; Group III application of 1.0 mg PGE2; Group IV PGE2 application of 2.0 mg PGE2. Total duration of parturition (time between first piglet and last placenta), piglet interval before and after treatment and placenta expulsion duration (time between first and last placenta) were recorded, and each piglet was scored for meconium staining and vitality. Furthermore, stillborn piglets were categorized into ante-partum and intra-partum deaths. A significant dose-dependent effect of PGE2 after the fourth piglet in a linear regression model with group I, II and III on the total duration of parturition and the placenta expulsion duration was detected. An increase of the PGE2 dosage from 0 to 1 mg significantly reduced the total duration of parturition (group I: 553.7 ± 114.2; group II:456 ± 167.9; group III: 284.7 ± 40.5; p-value: 0.02) and placenta expulsion duration (group I: 364 ± 120; group II: 289 ± 144.1; group III: 119 ± 46.13; p-value: 0.03). Although no further significant differences between the groups using ANCOVA and a linear regression model including all groups were detected, severe meconium staining in more than 10% of piglets was observed in group II and IV. Moreover, piglets of group IV showed oedematous and haemorrhagic umbilical cords, lethargy and anoxia after treatment, and intra-partum deaths were recorded. The best outcome for the sows and piglets was achieved using the 1 mg PGE2 dosage, whereas the other dosages showed more negative side effects, impairing the health and welfare of the animals. The results of this study can be used for further studies with larger sample sizes.
format Online
Article
Text
id pubmed-8017699
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80176992021-04-02 Observation of dose dependent intravaginal Prostaglandin E2 application in free farrowing sows during parturition – a pilot study Grahofer, Alexander Bill, Ramona Nathues, Heiko Porcine Health Manag Research The duration of birth is an important factor influencing the survival of piglets and the health of sows. A prolonged parturition is usually treated with oxytocin, even though several undesirable side effects are described. Therefore, the aim of this study was to evaluate the safety and efficacy of Prostaglandin E2 (PGE2) of different concentrations as an intravaginal applied gel after the birth of the fourth piglet in sows. Twelve sows were randomly allocated to one of four treatment groups: Group I (control group) application of placebo gel; Group II application of 0.5 mg; Group III application of 1.0 mg PGE2; Group IV PGE2 application of 2.0 mg PGE2. Total duration of parturition (time between first piglet and last placenta), piglet interval before and after treatment and placenta expulsion duration (time between first and last placenta) were recorded, and each piglet was scored for meconium staining and vitality. Furthermore, stillborn piglets were categorized into ante-partum and intra-partum deaths. A significant dose-dependent effect of PGE2 after the fourth piglet in a linear regression model with group I, II and III on the total duration of parturition and the placenta expulsion duration was detected. An increase of the PGE2 dosage from 0 to 1 mg significantly reduced the total duration of parturition (group I: 553.7 ± 114.2; group II:456 ± 167.9; group III: 284.7 ± 40.5; p-value: 0.02) and placenta expulsion duration (group I: 364 ± 120; group II: 289 ± 144.1; group III: 119 ± 46.13; p-value: 0.03). Although no further significant differences between the groups using ANCOVA and a linear regression model including all groups were detected, severe meconium staining in more than 10% of piglets was observed in group II and IV. Moreover, piglets of group IV showed oedematous and haemorrhagic umbilical cords, lethargy and anoxia after treatment, and intra-partum deaths were recorded. The best outcome for the sows and piglets was achieved using the 1 mg PGE2 dosage, whereas the other dosages showed more negative side effects, impairing the health and welfare of the animals. The results of this study can be used for further studies with larger sample sizes. BioMed Central 2021-04-02 /pmc/articles/PMC8017699/ /pubmed/33810812 http://dx.doi.org/10.1186/s40813-021-00208-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Grahofer, Alexander
Bill, Ramona
Nathues, Heiko
Observation of dose dependent intravaginal Prostaglandin E2 application in free farrowing sows during parturition – a pilot study
title Observation of dose dependent intravaginal Prostaglandin E2 application in free farrowing sows during parturition – a pilot study
title_full Observation of dose dependent intravaginal Prostaglandin E2 application in free farrowing sows during parturition – a pilot study
title_fullStr Observation of dose dependent intravaginal Prostaglandin E2 application in free farrowing sows during parturition – a pilot study
title_full_unstemmed Observation of dose dependent intravaginal Prostaglandin E2 application in free farrowing sows during parturition – a pilot study
title_short Observation of dose dependent intravaginal Prostaglandin E2 application in free farrowing sows during parturition – a pilot study
title_sort observation of dose dependent intravaginal prostaglandin e2 application in free farrowing sows during parturition – a pilot study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017699/
https://www.ncbi.nlm.nih.gov/pubmed/33810812
http://dx.doi.org/10.1186/s40813-021-00208-z
work_keys_str_mv AT grahoferalexander observationofdosedependentintravaginalprostaglandine2applicationinfreefarrowingsowsduringparturitionapilotstudy
AT billramona observationofdosedependentintravaginalprostaglandine2applicationinfreefarrowingsowsduringparturitionapilotstudy
AT nathuesheiko observationofdosedependentintravaginalprostaglandine2applicationinfreefarrowingsowsduringparturitionapilotstudy